SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-16-709663
Filing Date
2016-09-14
Accepted
2016-09-14 16:09:05
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B5 d234213d424b5.htm 424B5 318665
2 GRAPHIC g234213g02t18.jpg GRAPHIC 69605
3 GRAPHIC g234213g20j66.jpg GRAPHIC 116323
4 GRAPHIC g234213g32q38.jpg GRAPHIC 146437
5 GRAPHIC g234213g43p26.jpg GRAPHIC 95259
6 GRAPHIC g234213g53s82.jpg GRAPHIC 14262
7 GRAPHIC g234213g64z25.jpg GRAPHIC 107829
8 GRAPHIC g234213g83x05.jpg GRAPHIC 70547
9 GRAPHIC g234213g97k56.jpg GRAPHIC 52719
10 GRAPHIC g234213g98a48.jpg GRAPHIC 141495
  Complete submission text file 0001193125-16-709663.txt   1442593
Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Filer) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-206324 | Film No.: 161885193
SIC: 2834 Pharmaceutical Preparations